Could be. I followed CTIX for quite some time but never

New Post Public Reply Private Reply Replies (1) Message Board
joey68
Could be. I followed CTIX for quite some time but never invested because i felt it was going to continue in a downward trend; which it has.

Although not investment advice, CTIX was waaaaay overvalued last year. A company with a share price of several dollars should have a working product; CTIX did not.

This of course was the reason i refrained from investing. My gut told me the chart was going to correct itself. Even now, $1.25 share price is still overvalued. Im thinking CTX will probably even out at around .50 to .75 cents over the next several months.

Of course, back on track with AVXL... currently I see the share price of $3.37 to be extremely overvalued; despite them doing a reverse split.

I always classify my investments in one of two categories:

1. Make profit from a company knowing it probably wont go anywhere
and
2. Make profit from a company knowing it probably will go somewhere

The first one is for companies which make me a profit due to investor excitement; the 'hope' that the stock will run; knowing it will probably crash into oblivion, I sell, take my profit, and dont look back.

The second one is for companies which make me a profit because it is a serious company with real potential. These are my long plays; months to years. Im invested in several right now.

so to figure out where the heck im going with the blabbering post which probably makes no sense (I tend to ramble at times so much I even label some of my posts as "Random Ramblings"), i suppose what i am trying to say is that I classify AVXL somewhere between 1 and 2 for the time being. It will take many PRs and SEC filings to correct this issue and hopefully regain investor's trust that this product will actually work as expected. In the meantime, AVXL is more of a make profit in the short term play (if I were still invested).

Not investment advice.

Anavex Life Sciences Corp. (AVXL) Stock Research Links

AVXL Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 49

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading
Virginia Cancer Specialists: Leaders in Trusted Cancer Care

Updated Category News Views 69

Decades of Trust in Cancer Care Virginia Cancer Specialists isn't just another name in the sea of healthcare providers. That pride they're feeling? Well, they've got every right to it. Just slapped their physicians' names all over the latest Washingtonian's Top Doctors list for 2026. And this isn’t some under-the-table handshake deal. No, this list is shaped by peer...

Continue Reading
Heart Failure Certification Highlights Quality at Two Centers

Updated Category News Views 55

Celebrating Milestones in Healthcare Certification Out there in the Bronx, two skilled nursing facilities just snagged a certification that means they're playing in the big leagues of heart failure care. Holliswood Center and Bushwick Center, both under the Centers Health Care umbrella, have been awarded the Skilled Nursing Facility Heart Failure Certification from none...

Continue Reading
Radiation Oncologist Dr. Pennock Honored: A Closer Look

Updated Category News Views 56

An Honor from The Inner Circle Sometimes, in a field stuffed with brilliant minds, a beacon stands out. That's Dr. Michael M. Pennock for you—a man who doesn’t just treat cancer patients but transforms their journeys with precision and empathy. Recognized as a Pinnacle Lifetime Member by The Inner Circle, Pennock’s dedication in the field of radiation oncology is...

Continue Reading
California Cash Surplus Raises Investor Eyebrows

Updated Category News Views 44

California's Unexpected Financial Bounty Kicking things off with a real humdinger: California's September cash flow exceeded expectations by a whopping $2.9 billion. That's not chump change, folks. It's like finding an extra twenty in your coat pocket but on a much grander scale. Impressively, the state's General Fund receipts tallied up to $22.9 billion, surpassing the...

Continue Reading
Miracle League Marks Two Decades with Big Fundraising Win

Updated Category News Views 66

A Double Decade Celebration of Dream and Dedication The Miracle League of the Triangle sure knows how to throw a party—for them, it's not just a gala; it's a testament to two decades of turning dreams into reality. On October 13th, over 300 guests gathered at the Angus Barn Pavilion in Cary, NC, proving that passion for inclusive baseball is just as alive as it was 20...

Continue Reading
Ruizhi Unveils Trio of High-Tech Paper Bag Machines

Updated Category News Views 0

Cutting-Edge Unveiling at All in Print China 2026 In the bustling expo halls of the Shanghai New International Expo Centre, Ruizhi Machinery rolled out the red carpet for its latest inventions, stealing the limelight at the All in Print China 2026. Now, these were not your run-of-the-mill paper bag makers; we're talking about a set of machines that could redefine the gig...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 117

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Global Photo Contest Highlights Wetland Wonders

Updated Category News Views 50

Sparking Global Dialogue Through Photography Ever thought a photo could spark a conversation across continents? That's exactly what's happening with the 2026 Nandagang International Wetland Photo Contest. This ain't just any photo op—it's a call to action, a rallying cry using the beauty of nature to highlight the urgency of wetland conservation. From Local to Global:...

Continue Reading
Xyte's Record Quarter: Surging Demand & New CEO

Updated Category News Views 30

Setting New Records in the AV Industry There's buzz in the air over in Hoboken, New Jersey. Xyte, the AI cloud maestro you're starting to hear about more and more, has just smashed its own records this past September. It's not just a flash in the pan, either—this isn't the first time they've knocked it out of the park. Thanks to burgeoning enterprise demand and a...

Continue Reading

Top 5 Most Recently Viewed Articles

Future Growth of Edge AI Hardware: Trends and Insights

Updated Category News Views 184

The Expanding Edge AI Hardware Market The edge AI hardware market is on the brink of substantial growth, with projections indicating it will reach approximately USD 58.90 billion by the end of the decade. This growth is anticipated to accelerate from its current estimated value of USD 26.14 billion, showcasing an impressive compound annual growth rate (CAGR) of 17.6%. One...

Continue Reading
Orex Minerals Achieves Significant Gold-Silver Drill Results

Updated Category News Views 202

Exciting Gold-Silver Drilling Results at Coneto Orex Minerals Inc. has announced strong developments from its ongoing exploration efforts on the Coneto Gold-Silver Project. The company reported exceptional findings during the recently completed Phase-VI diamond drilling program that spanned over 2,000 metres across 8 drill holes. Highlighting the Loma Verde Vein The Loma...

Continue Reading
How Geopolitical Tensions and US Inflation Impact the Dollar

Updated Category News Views 191

Geopolitical Factors and the US Dollar In today's financial landscape, geopolitical events often capture more attention than traditional economic data, particularly in the case of the US dollar. Recent developments indicate that tensions around geopolitical issues could overshadow crucial US economic data. As traders and investors respond to these external factors, the...

Continue Reading
Polaris Renewable Energy's Q3 2024 Earnings: Performance Insights

Updated Category News Views 283

Polaris Renewable Energy Reports Q3 2024 Financial Results Polaris Renewable Energy Incorporated (TSX:PIF), a prominent player in the renewable energy sector, recently revealed its financial performance for the third quarter of 2024. The company experienced a reduction in power generation and revenue compared to the previous year. This decline saw production minimize to...

Continue Reading
Key Insights from Putin's Recent Annual News Conference

Updated Category News Views 114

Key Insights from Putin's Recent Annual News Conference During a noteworthy annual news conference, Russian President Vladimir Putin shared crucial insights that sparked attention on various international fronts. On Russia's Military Advances In discussing the new Oreshnik hypersonic missile, Putin confidently stated, "There is no chance of shooting down these missiles."...

Continue Reading